Full-thickness loss of articular cartilage will often progress until total destruction of a joint occurs. This in turn is extremely disabling, not only by limitation of function of a joint, but by producing severe pain. Left untreated, articular cartilage is not capable of repairing itself. Therefore, repairs of these lesions will require intervention with an implant that can bring the necessary elements for repair to the site of injury or disease. Work to date has shown that perichondrial tissue, when placed in a full-thickness articular cartilage defect, will proliferate and elaborate matrix that will repair the defect. However, perichondrium has limitations imposed by the amount of the tissue that is available for harvest and, in addition, it is technically challenging to attach to the cartilage defect. On the basis of prior research showing that the perichondrial cells are capable of performing as chondroprogenitor repair cells, the focus of this research has evolved to develop an optimized delivery system for treatment of an osteochondral defect. As conceptualized, this delivery system will consist of a two-layered, anatomically-modeled biodegradable (polylactic acid) scaffold which is seeded with cells cultured from perichondrium. The two-layered polylactic acid scaffold will have a superficial zone that will have a radially-oriented fiber construction, sitting atop a second layer that will have a randomly porous architecture. In addition, this carrier should be capable of delivery of growth factors. Based on the applicants' work, TGFbeta1 will be utilized to augment the cellular response at the repair site. The current proposal has three Specific Aims: 1) to evaluate an anatomic architecture of a polylactic acid biodegradable carrier; 2) to measure the effect of TGFbeta1 on the phenotype of cells grown in culture and its effect on facilitating cartilage repair; and 3) to assess repairs long-term, using an optimized carrier seeded with cultured perichondrial cells in a full-thickness articular cartilage defect in adult rabbits at one and two years post- implantation. The assessment of results will continue to be multidisciplinary, employing: 1) histomorphometric measurement of neocartilage height, area, surface roughness, cell density, subchondral bone restoration, and percent repair; 2) measurement of types I and II collagens by gel filtration HPLC; 3) in situ hybridization of tissue sections using cDNA or riboprobes specific for types I and II collagen mRNAs; 4) RT-PCR of RNA extracted from neocartilage repair tissue for type IX collagen mRNA expression; 5) immunohistochemistry to identify and biochemically characterize cartilage matrix marcomolecules (proteoglycan) at the repair site; 6) biomechanical quantitation of neocartilage and subchondral tissue compressive material properties by confined compression testing with video microscopy; and 7) biomechanical quantitation of neocartilage collagenous matrix function and host tissue integration by tensile testing to determine tissue tensile modulus. The goal is to develop an implant that will consistently and predictably produce repairs of full-thickness articular cartilage defects that will function as well as normal cartilage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR028467-18
Application #
6029929
Study Section
Special Emphasis Panel (ZRG4-ORTH (02))
Program Officer
Panagis, James S
Project Start
1981-04-01
Project End
2002-06-30
Budget Start
1999-07-01
Budget End
2002-06-30
Support Year
18
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Orthopedics
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Ball, Scott T; Goomer, Randal S; Ostrander, Roger V et al. (2004) Preincubation of tissue engineered constructs enhances donor cell retention. Clin Orthop Relat Res :276-85
Giurea, Alexander; Klein, Travis J; Chen, Albert C et al. (2003) Adhesion of perichondrial cells to a polylactic acid scaffold. J Orthop Res 21:584-9
Goomer, R S; Deftos, L J; Terkeltaub, R et al. (2001) High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects. Osteoarthritis Cartilage 9:248-56
Coutts, R D; Healey, R M; Ostrander, R et al. (2001) Matrices for cartilage repair. Clin Orthop Relat Res :S271-9
Ostrander, R V; Goomer, R S; Tontz, W L et al. (2001) Donor cell fate in tissue engineering for articular cartilage repair. Clin Orthop Relat Res :228-37
Lane, J G; Tontz Jr, W L; Ball, S T et al. (2001) A morphologic, biochemical, and biomechanical assessment of short-term effects of osteochondral autograft plug transfer in an animal model. Arthroscopy 17:856-63
Takahashi, K; Hashimoto, S; Kubo, T et al. (2001) Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 19:500-3
Takahashi, K; Hashimoto, S; Kubo, T et al. (2000) Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 27:1713-20
Dounchis, J S; Bae, W C; Chen, A C et al. (2000) Cartilage repair with autogenic perichondrium cell and polylactic acid grafts. Clin Orthop Relat Res :248-64
Goomer, R S; Maris, T M; Gelberman, R et al. (2000) Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin Orthop Relat Res :S189-200

Showing the most recent 10 out of 28 publications